Stockscreener 앱 받기
33.62
3.73%
1.21
시장 영업 전:
33.20
-0.42
-1.25%
Celldex Therapeutics Inc 주식(CLDX)의 최신 뉴스
Celldex prices $300M stock at $29 per share to fuel Barzolvolimab launch - MSN
Celldex Therapeutics announces public offering of common stock - MSN
A Look At Celldex Therapeutics (CLDX) Valuation After Equity Raise And New Barzolvolimab Data - Sahm
Precision Trading with Celldex Therapeutics Inc. (CLDX) Risk Zones - Stock Traders Daily
RSI Check: Why is Vistagen Therapeutics Inc stock going downBull Run & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Celldex Therapeutics Closes $345M Public Stock Offering - National Today
Celldex closes $345 million stock offering By Investing.com - Investing.com Australia
Celldex Therapeutics Completes $345 Million Public Offering of Common Stock - Quiver Quantitative
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - marketscreener.com
Did Celldex’s (CLDX) US$300 Million Equity Raise to Fund Barzolvolimab Just Shift Its Investment Narrative? - Sahm
Celldex Therapeutics, Inc. (CLDX) Options Chain - Yahoo! Finance Canada
Ambrosia, Syneron move toward clinic with nine-digit series B rounds: Finance Report - biocentury.com
JPMorgan Chase & Co. Sells 49,046 Shares of Celldex Therapeutics, Inc. $CLDX - MarketBeat
Celldex Announces Pricing of $300 Million Public Offering of Common Stock - Sahm
Celldex Therapeutics stock falls on equity offering - Investing.com
Celldex Therapeutics stock falls on equity offering By Investing.com - ca.investing.com
Celldex prices $300 million stock offering at $29 per share By Investing.com - Investing.com Australia
Celldex Therapeutics offers 10,345,000 shares of common stockSEC filing - marketscreener.com
Celldex Therapeutics (NASDAQ: CLDX) raises ~$282M net in $29 follow-on offering - Stock Titan
Celldex Therapeutics (NASDAQ:CLDX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Celldex shares plunge after dumping $300 million stock deal - gurufocus.com
Celldex Announces Major Underwritten Public Equity Offering - TipRanks
Celldex Therapeutics Inc (TCE2.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Celldex Therapeutics Prices $29 Share Sale, Expects $282 Million Net From Underwritten Offering - TradingView
Celldex (NASDAQ: CLDX) raises $300M in new common stock sale - Stock Titan
Is Celldex’s US$300 Million Follow-On To Fund Barzolvolimab Altering The Investment Case For CLDX? - Yahoo Finance
Celldex launches public offering of common stock By Investing.com - Investing.com South Africa
Celldex Therapeutics Inc (TCE2.DU) Stock Price, News, Quote & History - ca.finance.yahoo.com
Celldex Announces $300 Million Public Stock Offering - National Today
Celldex Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering of Common Stock - Quiver Quantitative
Celldex prices $300 million stock offering at $29 per share - Investing.com
Celldex lines up $300M for drug launch prep and pipeline work - Stock Titan
Celldex announces pricing of $300 million public offering of common stock - marketscreener.com
Celldex announces proposed public offering of common stock - marketscreener.com
Celldex launches public offering of common stock - Investing.com
Celldex Announces Proposed Public Offering of Common Stock - bitget.com
1.57%
1.10%
자본화:
|
볼륨(24시간):